Invert
Invert builds AI software for bioprocessing that unifies and contextualises time-series data across instruments, sites and CDMOs to support analytics and modelling.
Invert develops Bioprocess AI Software, a platform designed for the specific demands of bioprocessing. Its purpose is to unify and contextualise complex time-series data drawn from instruments, sites and CDMOs, turning fragmented records into AI-ready datasets. The software automates data cleaning and structuring, removing manual cleanup, and provides built-in visualisation, analytics and predictive modelling tools. Teams use it to plan, explore, analyse, model and collaborate across the path from laboratory to production.
The company's technical work spans artificial intelligence, time-series data processing, data unification and contextualisation, and bioprocess data infrastructure. A transparent AI interface is a stated design priority, allowing users to see how conclusions are reached rather than treating models as black boxes. This, combined with automated structuring of raw instrument data, is intended to reduce uncertainty in development and scale-up decisions.
Customers include biotech, pharmaceutical and manufacturing companies worldwide, among them contract development and manufacturing organisations. The platform is deployed across a global footprint and is applied in contexts where process data must be aggregated across multiple instruments, sites and partners. Invert describes its mission as helping customers deliver life-saving therapies and sustainable products faster.
